Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Protein Kinase, AMP-Activated, beta 2 Non-Catalytic Subunit (PRKAB2) (N-Term) Peptide

PRKAB2 Reactivité: Humain, Rat Hôte: Synthetic BP, WB
N° du produit ABIN982205

Aperçu rapide pour Protein Kinase, AMP-Activated, beta 2 Non-Catalytic Subunit (PRKAB2) (N-Term) Peptide (ABIN982205)

Antigène

PRKAB2 (Protein Kinase, AMP-Activated, beta 2 Non-Catalytic Subunit (PRKAB2))

Origine

Humain, Rat

Source

  • 2
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Séquence

    HKIMVGSTDD PSVFSLPDSK LPGDKEFVPW QQDLDDSVKP TQQARPTVIR

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-Prkab2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    PRKAB2 (Protein Kinase, AMP-Activated, beta 2 Non-Catalytic Subunit (PRKAB2))

    Sujet

    Prkab2 is a component of the AMPK alpha2beta2gamma1 complex which phosphorylates glycogen synthase.

    Alias Symbols: MGC93432

    Protein Size: 271

    Poids moléculaire

    29 kDa

    ID gène

    64562

    NCBI Accession

    NM_022627, NP_072149

    UniProt

    Q9QZH4
Vous êtes ici:
Chat with us!